{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T17:37:05Z","timestamp":1771695425308,"version":"3.50.1"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"S12","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1186\/s12859-016-1196-1","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T09:17:07Z","timestamp":1478596627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["How interacting pathways are regulated by miRNAs in breast cancer subtypes"],"prefix":"10.1186","volume":"17","author":[{"given":"Claudia","family":"Cava","sequence":"first","affiliation":[]},{"given":"Antonio","family":"Colaprico","sequence":"additional","affiliation":[]},{"given":"Gloria","family":"Bertoli","sequence":"additional","affiliation":[]},{"given":"Gianluca","family":"Bontempi","sequence":"additional","affiliation":[]},{"given":"Giancarlo","family":"Mauri","sequence":"additional","affiliation":[]},{"given":"Isabella","family":"Castiglioni","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"issue":"5","key":"1196_CR1","doi-asserted-by":"crossref","first-page":"e97681","DOI":"10.1371\/journal.pone.0097681","volume":"9","author":"C Cava","year":"2014","unstructured":"Cava C, Bertoli G, Ripamonti M, Mauri G, Zoppis I, Della Rosa PA, Gilardi MC, Castiglioni I. Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition. PLoS One. 2014;9(5):e97681.","journal-title":"PLoS One"},{"issue":"4","key":"1196_CR2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006;98(4):262\u201372.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1196_CR3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/1078-0432.CCR-14-2053","volume":"21","author":"PC Miller","year":"2015","unstructured":"Miller PC, Clarke J, Koru-Sengul T, Brinkman J, El-Ashry D. A novel MAPK-microRNA signature is predictive of hormone-therapy resistance and poor outcome in ER-positive breast cancer. Clin Cancer Res. 2015;21(2):373\u201385.","journal-title":"Clin Cancer Res"},{"key":"1196_CR4","first-page":"608","volume":"2013","author":"C Cava","year":"2013","unstructured":"Cava C, Zoppis I, Mauri G, Ripamonti M, Gallivanone F, Salvatore C, Gilardi MC, Castiglioni I. Combination of gene expression and genome copy number alteration has a prognostic value for breast cancer. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:608\u201311.","journal-title":"Conf Proc IEEE Eng Med Biol Soc."},{"key":"1196_CR5","doi-asserted-by":"crossref","unstructured":"Cava C, Zoppis I, Gariboldi M, Castiglioni I, Mauri G, Antoniotti M. Copy-number alterations for tumor progression inference. Artificial Intelligence in Medicine Volume 7885 of the series Lecture Notes in Computer Science, 2013 pp. 104-109.","DOI":"10.1007\/978-3-642-38326-7_16"},{"key":"1196_CR6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Elsen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature"},{"key":"1196_CR7","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1196_CR8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101:736\u201350.","journal-title":"J Natl Cancer Inst."},{"key":"1196_CR9","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","volume":"16","author":"M Dowsett","year":"2011","unstructured":"Dowsett M, Nielsen TO, A\u2019Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF, International Ki-67 in Breast Cancer Working Group. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst. 2011;16:1656\u201364.","journal-title":"J Natl Cancer Inst"},{"key":"1196_CR10","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492\u2013502.","journal-title":"JAMA."},{"key":"1196_CR11","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","volume":"16","author":"KM O'Brien","year":"2010","unstructured":"O'Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010;16:6100\u201310.","journal-title":"Clin Cancer Res."},{"issue":"1","key":"1196_CR12","doi-asserted-by":"crossref","first-page":"e53532","DOI":"10.1371\/journal.pone.0053532","volume":"8","author":"SV Iyer","year":"2013","unstructured":"Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, Shirsat NV, Dalal SN, Vaidya MM. Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines. PLoS One. 2013;8(1):e53532.","journal-title":"PLoS One"},{"issue":"6","key":"1196_CR13","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1245\/s10434-014-4313-2","volume":"22","author":"C Xu","year":"2015","unstructured":"Xu C, Wei Q, Guo J, Zhou JC, Mei J, Jiang ZN, Shen JG, Wang LB. FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients. Ann Surg Oncol. 2015;22(6):2034\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1196_CR14","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.ejca.2004.08.021","volume":"40","author":"T S\u00f8rlie","year":"2004","unstructured":"S\u00f8rlie T. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer. 2004;40:2667\u201375.","journal-title":"Eur J Cancer"},{"key":"1196_CR15","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817\u201326.","journal-title":"N Engl J Med."},{"key":"1196_CR16","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","volume":"11","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005;11:5678\u201385.","journal-title":"Clin Cancer Res."},{"key":"1196_CR17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/cncr.24876","volume":"116","author":"R Bhargava","year":"2010","unstructured":"Bhargava R, Beriwal S, Dabbs DJ, Ozbek U, Soran A, Johnson RR, Brufsky AM, Lembersky BC, Ahrendt GM. Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases. Cancer. 2010;116:1431\u20139.","journal-title":"Cancer."},{"issue":"47","key":"1196_CR18","first-page":"47ps43","volume":"2","author":"JS Reis-Filho","year":"2010","unstructured":"Reis-Filho JS, Weigelt B, Fumagalli D, Sotiriou C. Molecular profiling: moving away from tumor philately. Sci Transl Med. 2010;2(47):47ps43.","journal-title":"Sci Transl Med"},{"issue":"6","key":"1196_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/bcr2904","volume":"13","author":"B Tran","year":"2011","unstructured":"Tran B, Bedard PL. Luminal-B breast cancer and novel therapeutic targets. Breast Cancer Res. 2011;13(6):221.","journal-title":"Breast Cancer Res"},{"key":"1196_CR20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0959-8049(05)80137-6","volume":"29A","author":"JP Peyrat","year":"1993","unstructured":"Peyrat JP, Bonneterre J, Helquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer. 1993;29A:492\u20137.","journal-title":"Eur J Cancer"},{"key":"1196_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","volume":"8","author":"O Casanovas","year":"2005","unstructured":"Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF Signalling in late-stage pancreatic islet tumors. Cancer Cell. 2005;8:299\u2013309.","journal-title":"Cancer Cell"},{"key":"1196_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","volume":"16","author":"M Presta","year":"2005","unstructured":"Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16:159\u201378.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1196_CR23","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/0008-5472.CAN-09-3746","volume":"70","author":"N Turner","year":"2010","unstructured":"Turner N, Pearson A, Sharpe R, Lambros M, Geyer F, Lopez-Garcia MA, Natrajan R, Marchio C, Iorns E, Mackay A, Gillett C, Grigoriadis A, Tutt A, Reis-Filho JS, Ashworth A. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res. 2010;70:2085\u201394.","journal-title":"Cancer Res"},{"key":"1196_CR24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10549-009-0677-6","volume":"123","author":"CY Shiang","year":"2009","unstructured":"Shiang CY, Qi Y, Wang B, Lazar V, Wang J, Fraser Symmans W, Hortobagyi GN, Andre F, Pusztai L. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate. Breast Cancer Res Treat. 2009;123:747\u201355.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1196_CR25","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/bcr3449","volume":"15","author":"EM Fox","year":"2013","unstructured":"Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL. Autocrine IGF-I\/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation. Breast Cancer Res. 2013;15(4):R55.","journal-title":"Breast Cancer Res"},{"key":"1196_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11523-009-0123-z","volume":"4","author":"F Atzori","year":"2009","unstructured":"Atzori F, Traina TA, Ionta MT, Massidda B. Targeting insulin-like growth factor type 1 receptor in cancer therapy. Target Oncol. 2009;4:255\u201366.","journal-title":"Target Oncol"},{"key":"1196_CR27","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/bcr2594","volume":"12","author":"CJ Creighton","year":"2010","unstructured":"Creighton CJ, Fu X, Hennessy BT, Casa AJ, Zhang Y, Gonzalez-Angulo AM, Lluch A, Gray JW, Brown PH, Hilsenbeck SG, Osborne CK, Mills GB, Lee AV, Schiff R. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer. Breast Cancer Res. 2010;12:R40.","journal-title":"Breast Cancer Res"},{"key":"1196_CR28","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.ejca.2009.06.027","volume":"45","author":"F Heitz","year":"2009","unstructured":"Heitz F, Harter P, Lueck HJ, Fissler-Eckhoff A, Lorenz-Salehi F, Scheil-Bertram S, Traut A, du Bois A. Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. Eur J Cancer. 2009;45:2792\u20138.","journal-title":"Eur J Cancer."},{"key":"1196_CR29","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1196_CR30","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, B\u00e9gin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95:1482\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 8","key":"1196_CR31","doi-asserted-by":"crossref","first-page":"viii13","DOI":"10.1093\/annonc\/mdt306","volume":"24","author":"S Summa De","year":"2013","unstructured":"De Summa S, Pinto R, Sambiasi D, Petriella D, Paradiso V, Paradiso A, et al. BRCAness: a deeper insight into basal-like breast tumors. Ann Oncol. 2013;24 Suppl 8:viii13\u201321.","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"1196_CR32","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","volume":"9","author":"CK Anders","year":"2009","unstructured":"Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9 Suppl 2:S73\u201381.","journal-title":"Clin Breast Cancer."},{"issue":"2","key":"1196_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/me.2010-0164","volume":"25","author":"DJ Toft","year":"2011","unstructured":"Toft DJ, Cryns VL. Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. Mol Endocrinol. 2011;25(2):199\u2013211.","journal-title":"Mol Endocrinol"},{"key":"1196_CR34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrclinonc.2009.130","volume":"6","author":"SP Ivy","year":"2009","unstructured":"Ivy SP, Wick JY, Kaufman BM. An overview of small-molecule inhibitors of VEGFR Signalling. Nat Rev Clin Oncol. 2009;6:569\u201379.","journal-title":"Nat Rev Clin Oncol."},{"key":"1196_CR35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2007.13.5939","volume":"26","author":"M Guix","year":"2008","unstructured":"Guix M, Granja Nde M, Meszoely I, Adkins TB, Wieman BM, Frierson KE, Sanchez V, Sanders ME, Grau AM, Mayer IA, Pestano G, Shyr Y, Muthuswamy S, Calvo B, Krontiras H, Krop IE, Kelley MC, Arteaga CL. Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers. J Clin Oncol. 2008;26:897\u2013906.","journal-title":"J Clin Oncol."},{"issue":"3","key":"1196_CR36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","volume":"5","author":"O Yersal","year":"2014","unstructured":"Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412\u201324.","journal-title":"World J Clin Oncol"},{"key":"1196_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsbmb.2015.05.005","volume":"153","author":"VS Wu","year":"2015","unstructured":"Wu VS, Kanaya N, Lo C, Mortimer J, Chen S. From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer? J Steroid Biochem Mol Biol. 2015;153:45\u201353.","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"2","key":"1196_CR38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01961241","volume":"24","author":"CC Benz","year":"1992","unstructured":"Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM, Osborne CK. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2\/neu. Breast Cancer Res Treat. 1992;24(2):85\u201395.","journal-title":"Breast Cancer Res Treat"},{"key":"1196_CR39","doi-asserted-by":"crossref","unstructured":"Colaprico A, Cava C, Bertoli G, Bontempi G, Castiglioni I. Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer. Biomed Res Int. 2015;2015:831314.","DOI":"10.1155\/2015\/831314"},{"issue":"9","key":"1196_CR40","doi-asserted-by":"crossref","first-page":"e1003851","DOI":"10.1371\/journal.pcbi.1003851","volume":"10","author":"S Huang","year":"2014","unstructured":"Huang S, Yee C, Ching T, Yu H, Garmire LX. A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer. PLoS Comput Biol. 2014;10(9):e1003851.","journal-title":"PLoS Comput Biol"},{"key":"1196_CR41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","volume":"439","author":"AH Bild","year":"2006","unstructured":"Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439:353\u20137.","journal-title":"Nature."},{"key":"1196_CR42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/acel.12160","volume":"13","author":"EB Akker van den","year":"2013","unstructured":"van den Akker EB, Passtoors WM, Jansen R, van Zwet EW, Goeman JJ, et al. Meta-analysis on blood transcriptomic studies identifies consistently coexpressed protein-protein interaction modules as robust markers of human aging. Aging Cell. 2013;13:216\u201325.","journal-title":"Aging Cell."},{"issue":"8","key":"1196_CR43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2013.03.009","volume":"39","author":"KS Saini","year":"2013","unstructured":"Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M, Dancey JE, Piccart-Gebhart MJ. Targeting the PI3K\/AKT\/mTOR and Raf\/MEK\/ERK pathways in the treatment of breast cancer. Cancer Treat Rev. 2013;39(8):935\u201346.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"1196_CR44","first-page":"197","volume":"1815","author":"S Guo","year":"2011","unstructured":"Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic Signalling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815(2):197\u2013213.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1196_CR45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/MCB.00821-10","volume":"31","author":"Z Madak-Erdogan","year":"2011","unstructured":"Madak-Erdogan Z, Lupien M, Stossi F, Brown M, Katzenellenbogen BS. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol Cell Biol. 2011;31(1):226\u201336.","journal-title":"Mol Cell Biol"},{"key":"1196_CR46","doi-asserted-by":"crossref","first-page":"e40358","DOI":"10.1371\/journal.pone.0040358","volume":"7","author":"MH Vliet van","year":"2012","unstructured":"van Vliet MH, Horlings HM, van de Vijver MJ, Reinders MJ, Wessels LF. Integration of clinical and gene expression data has a synergetic effect on predicting breast cancer outcome. PLoS One. 2012;7:e40358.","journal-title":"PLoS One."},{"key":"1196_CR47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-8794-4-5","volume":"4","author":"S Ma","year":"2011","unstructured":"Ma S, Kosorok MR, Huang J, Dai Y. Incorporating higher-order representative features improves prediction in network-based cancer prognosis analysis. BMC Med Genomics. 2011;4:5.","journal-title":"BMC Med Genomics."},{"key":"1196_CR48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-2105-11-277","volume":"11","author":"G Abraham","year":"2010","unstructured":"Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J. Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics. 2010;11:277.","journal-title":"BMC Bioinformatics"},{"key":"1196_CR49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphys.2013.00124","volume":"4","author":"T Kessler","year":"2013","unstructured":"Kessler T, Hache H, Wierling C. Integrative analysis of cancer-related Signalling pathways. Front Physiol. 2013;4:124.","journal-title":"Front Physiol."},{"key":"1196_CR50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","volume":"136","author":"A Ventura","year":"2009","unstructured":"Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136:586\u201391.","journal-title":"Cell"},{"key":"1196_CR51","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1196_CR52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451:147\u201352.","journal-title":"Nature"},{"key":"1196_CR53","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1038\/onc.2013.492","volume":"33","author":"X Sun","year":"2014","unstructured":"Sun X, Jiao X, Pestell TG, et al. MicroRNAs and cancer stem cells: the sword and the shield. Oncogene. 2014;33:4967\u201377.","journal-title":"Oncogene"},{"key":"1196_CR54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10549-010-0954-4","volume":"126","author":"H Li","year":"2011","unstructured":"Li H, Bian C, Liao L, et al. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat. 2011;126:565\u201375.","journal-title":"Breast Cancer Res Treat"},{"key":"1196_CR55","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ijo.2013.2059","volume":"43","author":"R Piva","year":"2013","unstructured":"Piva R, Spandidos DA, Gambari R. From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review). Int J Oncol. 2013;43:985\u201394.","journal-title":"Int J Oncol"},{"key":"1196_CR56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5306\/wjco.v5.i2.71","volume":"5","author":"GS Christodoulatos","year":"2014","unstructured":"Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? World J Clin Oncol. 2014;5:71\u201381.","journal-title":"World J Clin Oncol"},{"key":"1196_CR57","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.humpath.2013.01.023","volume":"44","author":"M Fassan","year":"2013","unstructured":"Fassan M, Pizzi M, Realdon S, et al. The HER2-miR125a5p\/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol. 2013;44:1804\u201310.","journal-title":"Hum Pathol"},{"key":"1196_CR58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-5-24","volume":"5","author":"MD Mattie","year":"2006","unstructured":"Mattie MD, Benz CC, Bowers J, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006;5:24.","journal-title":"Mol Cancer"},{"key":"1196_CR59","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1074\/jbc.M609383200","volume":"282","author":"GK Scott","year":"2007","unstructured":"Scott GK, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 2007;282:1479\u201386.","journal-title":"J Biol Chem"},{"key":"1196_CR60","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1038\/emboj.2011.312","volume":"30","author":"J Yun","year":"2011","unstructured":"Yun J, Frankenberger CA, Kuo WL, et al. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J. 2011;30:4500\u201314.","journal-title":"EMBO J"},{"key":"1196_CR61","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1158\/0008-5472.CAN-08-0180","volume":"68","author":"N Kondo","year":"2008","unstructured":"Kondo N, Toyama T, Sugiura H, et al. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 2008;68:5004\u20138.","journal-title":"Cancer Res"},{"key":"1196_CR62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0300060513485856","volume":"41","author":"Y Li","year":"2013","unstructured":"Li Y, Hong F, Yu Z. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival. J Int Med Res. 2013;41:596\u2013602.","journal-title":"J Int Med Res"},{"key":"1196_CR63","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1038\/oncsis.2014.26","volume":"3","author":"SJ Elliman","year":"2014","unstructured":"Elliman SJ, Howley BV, Mehta DS, et al. Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers. Oncogenesis. 2014;3:e113.","journal-title":"Oncogenesis"},{"key":"1196_CR64","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1210\/me.2007-0022","volume":"21","author":"BD Adams","year":"2007","unstructured":"Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (NA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol. 2007;21:1132\u201347.","journal-title":"Mol Endocrinol"},{"key":"1196_CR65","doi-asserted-by":"crossref","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, Ceccarelli M, Bontempi G, Noushmehr H. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","DOI":"10.1093\/nar\/gkv1507"},{"issue":"1","key":"1196_CR66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B (Methodological). 1995;57(1):289\u2013300.","journal-title":"J Royal Stat Soc Series B (Methodological)"},{"issue":"3","key":"1196_CR67","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M. Classification and regression by randomForest. R news. 2002;2(3):18\u201322.","journal-title":"R news"},{"issue":"6","key":"1196_CR68","doi-asserted-by":"crossref","first-page":"066138","DOI":"10.1103\/PhysRevE.69.066138","volume":"69","author":"A Kraskov","year":"2004","unstructured":"Kraskov A, Stogbauer H, Grassberger P. Estimating mutual information. Physical review E. 2004;69(6):066138.","journal-title":"Physical review E"},{"issue":"13","key":"1196_CR69","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/bioinformatics\/btr274","volume":"27","author":"G Sales","year":"2011","unstructured":"Sales G, Romualdi C. parmigene--a parallel R package for mutual information estimation and gene network reconstruction. Bioinformatics. 2011;27(13):1876\u20137.","journal-title":"Bioinformatics"},{"issue":"1","key":"1196_CR70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0037-1614212","volume":"79","author":"A Falanga","year":"1998","unstructured":"Falanga A, Levine MN, Consonni R, Gritti G, Delaini F, Oldani E, Julian JA, Barbui T. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial. Thromb Haemost. 1998;79(1):23\u20137.","journal-title":"Thromb Haemost"},{"issue":"6","key":"1196_CR71","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cpr.12146","volume":"47","author":"Z Yang","year":"2014","unstructured":"Yang Z, Han Y, Cheng K, Zhang G, Wang X. miR-99a directly targets the Mtor signalling pathway in breast cancer side population cells. Cell Prolif. 2014;47(6):587\u201395.","journal-title":"Cell Prolif"},{"issue":"19","key":"1196_CR72","first-page":"2783","volume":"18","author":"EH Sun","year":"2014","unstructured":"Sun EH, Zhou Q, Liu KS, Wei W, Wang CM, Liu XF, Lu C, Ma DY. Screening miRNAs related to different subtypes of breast cancer with miRNAs microarray. Eur Rev Med Pharmacol Sci. 2014;18(19):2783\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1196_CR73","first-page":"46","volume":"25","author":"J Liu","year":"2013","unstructured":"Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res. 2013;25(1):46\u201354.","journal-title":"Chin J Cancer Res"},{"key":"1196_CR74","first-page":"106197","volume":"2014","author":"M Li","year":"2014","unstructured":"Li M, Ma X, Li M, Zhang B, Huang J, Liu L, Wei Y. Prognostic role of microRNA-210 in various carcinomas: a systematic review and meta-analysis. Dis Markers. 2014;2014:106197.","journal-title":"Dis Markers."},{"issue":"10","key":"1196_CR75","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/cncr.26565","volume":"118","author":"EJ Jung","year":"2012","unstructured":"Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E, Buzdar AU, Di Leo A, Le XF, Bast Jr RC, Park ST, Pusztai L, Calin GA. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer. 2012;118(10):2603\u201314.","journal-title":"Cancer"},{"issue":"10","key":"1196_CR76","doi-asserted-by":"publisher","first-page":"e0139305","DOI":"10.1371\/journal.pone.0139305","volume":"10","author":"T Voigtl\u00e4nder","year":"2015","unstructured":"Voigtl\u00e4nder T, Gupta SK, Thum S, Fendrich J, Manns MP, Lankisch TO, Thum T. MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and\/or Cholangiocarcinoma. PLoS One. 2015;10(10):e0139305. doi: 10.1371\/journal.pone.0139305 .","journal-title":"PLoS One"},{"issue":"1","key":"1196_CR77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12953-014-0059-9","volume":"13","author":"K Davalieva","year":"2015","unstructured":"Davalieva K, Kiprijanovska S, Komina S, Petrusevska G, Zografska NC, Polenakovic M. Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer. Proteome Sci. 2015;13(1):2.","journal-title":"Proteome Sci"},{"key":"1196_CR78","doi-asserted-by":"crossref","unstructured":"Eltzschig HK, Carmeliet P. Hypoxia and inflammation. New England Journal of Medicine. 2011;364(7):656\u201365.","DOI":"10.1056\/NEJMra0910283"},{"issue":"4","key":"1196_CR79","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molonc.2012.03.003","volume":"6","author":"C Piovan","year":"2012","unstructured":"Piovan C, Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CM. Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol Oncol. 2012;6(4):458\u201372.","journal-title":"Mol Oncol"},{"issue":"24","key":"1196_CR80","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1158\/0008-5472.CAN-07-5019","volume":"67","author":"LF Sempere","year":"2007","unstructured":"Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007;67(24):11612\u201320.","journal-title":"Cancer Res"},{"issue":"10","key":"1196_CR81","doi-asserted-by":"crossref","first-page":"e76402","DOI":"10.1371\/journal.pone.0076402","volume":"8","author":"OA Elgamal","year":"2013","unstructured":"Elgamal OA, Park JK, Gusev Y, Azevedo-Pouly AC, Jiang J, Roopra A, Schmittgen TD. Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS One. 2013;8(10):e76402.","journal-title":"PLoS One"},{"issue":"3","key":"1196_CR82","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrc3005","volume":"11","author":"P Mehlen","year":"2011","unstructured":"Mehlen P, Delloye-Bourgeois C, Ch\u00e9dotal A. Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nat Rev Cancer. 2011;11(3):188\u201397.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1196_CR83","doi-asserted-by":"crossref","first-page":"e104870","DOI":"10.1371\/journal.pone.0104870","volume":"9","author":"Q Li","year":"2014","unstructured":"Li Q, Liu M, Ma F, Luo Y, Cai R, Wang L, Xu N, Xu B. Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel. PLoS One. 2014;9(8):e104870.","journal-title":"PLoS One"},{"key":"1196_CR84","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1073\/pnas.1212811109","volume":"109","author":"C Polytarchou","year":"2012","unstructured":"Polytarchou C, Iliopoulos D, Struhl K. An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state. Proc Natl Acad Sci U S A. 2012;109:14470\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1196_CR85","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molmed.2011.01.006","volume":"17","author":"CA Andorfer","year":"2011","unstructured":"Andorfer CA, Necela BM, Thompson EA, Perez EA. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med. 2011;17:313\u20139.","journal-title":"Trends Mol Med"},{"issue":"5","key":"1196_CR86","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/carcin\/bgs114","volume":"33","author":"J Lynch","year":"2012","unstructured":"Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, Stallings RL. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-\u03b2 signalling pathway. Carcinogenesis. 2012;33(5):976\u201385.","journal-title":"Carcinogenesis"},{"key":"1196_CR87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1756-9966-32-76","volume":"32","author":"Z Wang","year":"2013","unstructured":"Wang Z, Wang J, Yang Y, Hao B, Wang R, Li Y, Wu Q. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J Exp Clin Cancer Res. 2013;32:76.","journal-title":"J Exp Clin Cancer Res."},{"issue":"10","key":"1196_CR88","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.acuro.2014.02.008","volume":"38","author":"V Medina-Villaamil","year":"2014","unstructured":"Medina-Villaamil V, Mart\u00ednez-Breijo S, Portela-Pereira P, Quind\u00f3s-Varela M, Santamarina-Ca\u00ednzos I, Ant\u00f3n-Aparicio LM, G\u00f3mez-Veiga F. Circulating MicroRNAs in blood of patients with prostate cancer. Actas Urol Esp. 2014;38(10):633\u20139.","journal-title":"Actas Urol Esp"},{"issue":"13","key":"1196_CR89","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.7314\/APJCP.2014.15.13.5137","volume":"15","author":"Q Hu","year":"2014","unstructured":"Hu Q, Gong JP, Li J, Zhong SL, Chen WX, Zhang JY, Ma TF, Ji H, Lv MM, Zhao JH, Tang JH. Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells. Asian Pac J Cancer Prev. 2014;15(13):5137\u201342.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"1196_CR90","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1007\/s13277-014-1834-z","volume":"35","author":"Q Hu","year":"2014","unstructured":"Hu Q, Chen WX, Zhong SL, Zhang JY, Ma TF, Ji H, Lv MM, Tang JH, Zhao JH. MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells. Tumour Biol. 2014;35(7):6327\u201334.","journal-title":"Tumour Biol"},{"key":"1196_CR91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fgene.2012.00046","volume":"3","author":"O Faria de Jr","year":"2012","unstructured":"de Faria Jr O, Cui QL, Bin JM, Bull SJ, Kennedy TE, Bar-Or A, Antel JP, Colman DR, Dhaunchak AS. Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes. Front Genet. 2012;3:46. doi: 10.3389\/fgene.2012.00046 . eCollection 2012. PubMed PMID: 22470405.","journal-title":"Front Genet"},{"issue":"9","key":"1196_CR92","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","volume":"10","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Giacomantonio CA, Patrick WK L. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011;10(9):1378\u201384.","journal-title":"Cell Cycle"},{"issue":"3","key":"1196_CR93","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/bcr3663","volume":"16","author":"G Honeth","year":"2014","unstructured":"Honeth G, Lombardi S, Ginestier C, Hur M, Marlow R, Buchupalli B, Shinomiya I, Gazinska P, Bombelli S, Ramalingam V, Purushotham AD, Pinder SE, Dontu G. Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium. Breast Cancer Res. 2014;16(3):R52.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"1196_CR94","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/bcr3061","volume":"13","author":"HR Ali","year":"2011","unstructured":"Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C. Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance. Breast Cancer Res. 2011;13(6):R118.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1196_CR95","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/modpathol.2011.172","volume":"25","author":"T Khoury","year":"2012","unstructured":"Khoury T, Ademuyiwa FO, Chandrasekhar R, Jabbour M, Deleo A, Ferrone S, Wang Y, Wang X. Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy. Mod Pathol. 2012;25(3):388\u201397.","journal-title":"Mod Pathol"},{"issue":"8","key":"1196_CR96","doi-asserted-by":"publisher","first-page":"a013540","DOI":"10.1101\/cshperspect.a013540","volume":"4","author":"R Talhouk","year":"2012","unstructured":"Talhouk R. On cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb Perspect Biol. 2012;4(8):a013540. doi: 10.1101\/cshperspect.a013540 .","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"20","key":"1196_CR97","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1182\/blood-2011-12-395939","volume":"119","author":"A Troeger","year":"2012","unstructured":"Troeger A, Johnson AJ, Wood J, Blum WG, Andritsos LA, Byrd JC, Williams DA. RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans. Blood. 2012;119(20):4708\u201318. doi: 10.1182\/blood-2011-12-395939 .","journal-title":"Blood"},{"issue":"4","key":"1196_CR98","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1083\/jcb.201501072","volume":"211","author":"AE Dart","year":"2015","unstructured":"Dart AE, Box GM, Court W, Gale ME, Brown JP, Pinder SE, Eccles SA, Wells CM. PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. J Cell Biol. 2015;211(4):863\u201379. doi: 10.1083\/jcb.201501072 .","journal-title":"J Cell Biol"},{"issue":"8","key":"1196_CR99","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.steroids.2011.02.023","volume":"76","author":"CX Ma","year":"2011","unstructured":"Ma CX, Crowder RJ, Ellis MJ. Importance of PI3-kinase pathway in response\/resistance to aromatase inhibitors. Steroids. 2011;76(8):750\u20132. doi: 10.1016\/j.steroids.2011.02.023 . Epub 2011 Mar 21.","journal-title":"Steroids"},{"issue":"8","key":"1196_CR100","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00018-013-1376-3","volume":"71","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Qiao JX, Shetty A, Wu G, Huang Y, Davidson NE, Wan Y. Regulation of estrogen receptor Signalling in breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci. 2014;71(8):1549. doi: 10.1007\/s00018-013-1376-3 . Retraction in: Cell Mol Life Sci. 2014 Apr;71(8):1549.","journal-title":"Cell Mol Life Sci"},{"key":"1196_CR101","first-page":"428371","volume":"2014","author":"C Han","year":"2014","unstructured":"Han C, Yu Z, Duan Z, Kan Q. Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int. 2014;2014:428371.","journal-title":"Biomed Res Int."},{"issue":"4","key":"1196_CR102","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1158\/1541-7786.MCR-11-0342","volume":"10","author":"JF Reid","year":"2012","unstructured":"Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S, Gariboldi M, Pierotti MA. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res. 2012;10(4):504\u201315.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1196_CR103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12253-014-9818-2","volume":"21","author":"K Pavlakis","year":"2015","unstructured":"Pavlakis K, Bobos M, Batistatou A, Kotoula V, Eleftheraki AG, Stofas A, Timotheadou E, Pentheroudakis G, Psyrri A, Koutras A, Pectasides D, Papakostas P, Razis E, Christodoulou C, Kalogeras KT, Fountzilas G. p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab. Pathol Oncol Res. 2015;21(2):273\u201382. doi: 10.1007\/s12253-014-9818-2 .","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"1196_CR104","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/carcin\/bgn126","volume":"29","author":"A Brendle","year":"2008","unstructured":"Brendle A, Lei H, Brandt A, Johansson R, Enquist K, Henriksson R, Hemminki K, Lenner P, F\u00f6rsti A. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis. 2008;29(7):1394\u20139. doi: 10.1093\/carcin\/bgn126 .","journal-title":"Carcinogenesis"},{"issue":"Pt15","key":"1196_CR105","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1242\/jcs.103861","volume":"125","author":"W Shih","year":"2012","unstructured":"Shih W, Yamada S. N-cadherin-mediated cell-cell adhesion promotes cell migration in a three-dimensional matrix. J Cell Sci. 2012;125(Pt15):3661\u201370.","journal-title":"J Cell Sci"},{"key":"1196_CR106","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999\u20133004.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1196_CR107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1476-4598-12-30","volume":"12","author":"W Wu","year":"2013","unstructured":"Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer. 2013;12:30.","journal-title":"Mol Cancer."},{"issue":"16","key":"1196_CR108","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1097\/MD.0000000000000767","volume":"94","author":"YZ Ge","year":"2015","unstructured":"Ge YZ, Xu LW, Xu Z, Wu R, Xin H, Zhu M, Lu TZ, Geng LG, Liu H, Zhou CC, Yu P, Zhao YC, Hu ZK, Zhao Y, Zhou LH, Wu JP, Li WC, Zhu JG, Jia RP. Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study. Medicine (Baltimore). 2015;94(16):e767. doi: 10.1097\/MD.0000000000000767 .","journal-title":"Medicine (Baltimore)"},{"key":"1196_CR109","doi-asserted-by":"publisher","unstructured":"Zhang W, Shen C, Li C, Yang G, Liu H, Chen X, Zhu D, Zou H, Zhen Y, Zhang D, Zhao S. miR-577 inhibits glioblastoma tumor growth via the Wnt Signalling pathway. Mol Carcinog. 2015 Mar 12. doi: 10.1002\/mc.22304","DOI":"10.1002\/mc.22304"},{"issue":"11","key":"1196_CR110","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.apjtm.2015.10.001","volume":"8","author":"LY Wang","year":"2015","unstructured":"Wang LY, Li B, Jiang HH, Zhuang LW, Liu Y. Inhibition effect of miR-577 on hepatocellular carcinoma cell growth via targeting \u03b2-catenin. Asian Pac J Trop Med. 2015;8(11):923\u20139. doi: 10.1016\/j.apjtm.2015.10.001 .","journal-title":"Asian Pac J Trop Med"},{"issue":"12","key":"1196_CR111","first-page":"2651","volume":"6","author":"X Yuan","year":"2013","unstructured":"Yuan X, He J, Sun F, Gu J. Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2013;6(12):2651\u201367.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"1196_CR112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/cr.2007.115","volume":"18","author":"GM Li","year":"2008","unstructured":"Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18(1):85\u201398.","journal-title":"Cell Res"},{"key":"1196_CR113","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2257","volume":"11","author":"AJ Lowery","year":"2009","unstructured":"Lowery AJ, Miller N, Devaney A, et al. MicroRNA signatures predict estrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer. Breast Cancer Res. 2009;11:R27.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"1196_CR114","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2014.03.006","volume":"25","author":"N Valeri","year":"2014","unstructured":"Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat F, Paone A, Cascione L, Sumani KM, Veronese A, Fabbri M, Carasi S, Alder H, Lanza G, Gafa\u2019 R, Moyer MP, Ridgway RA, Cordero J, Nuovo GJ, Frankel WL, Rugge M, Fassan M, Groden J, Vogt PK, Karin M, Sansom OJ, Croce CM. MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell. 2014;25(4):469\u201383.","journal-title":"Cancer Cell"},{"issue":"4","key":"1196_CR115","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1074\/jbc.270.4.1695","volume":"270","author":"M Lessard","year":"1995","unstructured":"Lessard M, Zhao C, Singh SM, Poulin R. Hormonal and feedback regulation of putrescine and spermidine transport in human breast cancer cells. J Biol Chem. 1995;270(4):1685\u201394.","journal-title":"J Biol Chem"},{"issue":"1","key":"1196_CR116","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biocel.2009.07.009","volume":"42","author":"K Igarashi","year":"2010","unstructured":"Igarashi K, Kashiwagi K. Modulation of cellular function by polyamines. Int J Biochem Cell Biol. 2010;42(1):39\u201351.","journal-title":"Int J Biochem Cell Biol"},{"issue":"Pt 6","key":"1196_CR117","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1242\/jcs.095976","volume":"125","author":"R Singh","year":"2012","unstructured":"Singh R, Saini N. Downregulation of BCL2 by miRNAs augments drug-induced apoptosis--a combined computational and experimental approach. J Cell Sci. 2012;125(Pt 6):1568\u201378.","journal-title":"J Cell Sci"},{"issue":"2","key":"1196_CR118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cellsig.2013.11.003","volume":"26","author":"S Hamada","year":"2014","unstructured":"Hamada S, Masamune A, Miura S, Satoh K, Shimosegawa T. MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX. Cell Signal. 2014;26(2):179\u201385.","journal-title":"Cell Signal"},{"key":"1196_CR119","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/1535-7163.MCT-08-0538","volume":"7","author":"AM Gasparri","year":"2008","unstructured":"Gasparri AM, Jachetti E, Colombo B, Sacchi A, Curnis F, Rizzardi GP, Traversari C, Bellone M, Corti A. Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma. Mol Cancer Ther. 2008;7:3859\u201366.","journal-title":"Mol Cancer Ther."},{"issue":"4","key":"1196_CR120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3349\/ymj.2016.57.4.865","volume":"57","author":"WT Kim","year":"2016","unstructured":"Kim WT, Yun SJ, Yan C, Jeong P, Kim YH, Lee IS, Kang HW, Park S, Moon SK, Choi YH, Choi YD, Kim IY, Kim J, Kim WJ. Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls. Yonsei Med J. 2016;57(4):865\u201371.","journal-title":"Yonsei Med J"},{"issue":"2","key":"1196_CR121","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1535-7163.MCT-09-0628","volume":"9","author":"HK Koblish","year":"2010","unstructured":"Koblish HK, Hansbury MJ, Bowman KJ, Yang G, Neilan CL, Haley PJ, Burn TC, Waeltz P, Sparks RB, Yue EW, Combs AP, Scherle PA, Vaddi K, Fridman JS. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. Mol Cancer Ther. 2010;9(2):489\u201398.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"1196_CR122","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove C, Pilotte L, Th\u00e9ate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med. 2003;9(10):1269\u201374.","journal-title":"Nat Med"},{"issue":"3","key":"1196_CR123","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","volume":"11","author":"AJ Muller","year":"2005","unstructured":"Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med. 2005;11(3):312\u20139.","journal-title":"Nat Med"},{"issue":"6","key":"1196_CR124","doi-asserted-by":"crossref","first-page":"e0130032","DOI":"10.1371\/journal.pone.0130032","volume":"10","author":"K Nobutani","year":"2015","unstructured":"Nobutani K, Shimono Y, Mizutani K, Ueda Y, Suzuki T, Kitayama M, Minami A, Momose K, Miyawaki K, Akashi K, Azuma T, Takai Y. Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy. PLoS One. 2015;10(6):e0130032.","journal-title":"PLoS One"},{"issue":"7","key":"1196_CR125","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/jcmm.12536","volume":"19","author":"Y Zhan","year":"2015","unstructured":"Zhan Y, Zhang H, Li J, Zhang Y, Zhang J, He L. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4. J Cell Mol Med. 2015;19(7):1614\u201323.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1196_CR126","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1523\/JNEUROSCI.23-04-01360.2003","volume":"23","author":"SH Chalasani","year":"2003","unstructured":"Chalasani SH, Sabelko KA, Sunshine MJ, Littman DR, Raper JA. A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding. J Neurosci. 2003;23(4):1360\u201371.","journal-title":"J Neurosci"},{"issue":"3","key":"1196_CR127","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1096\/fj.12-214692","volume":"27","author":"D Cimino","year":"2013","unstructured":"Cimino D, De Pitt\u00e0 C, Orso F, Zampini M, Casara S, Penna E, Quaglino E, Forni M, Damasco C, Pinatel E, Ponzone R, Romualdi C, Brisken C, De Bortoli M, Biglia N, Provero P, Lanfranchi G, Taverna D. miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J. 2013;27(3):1223\u201335.","journal-title":"FASEB J"},{"issue":"10","key":"1196_CR128","doi-asserted-by":"crossref","first-page":"e76729","DOI":"10.1371\/journal.pone.0076729","volume":"8","author":"K Cuk","year":"2013","unstructured":"Cuk K, Zucknick M, Madhavan D, Schott S, Golatta M, Heil J, Marm\u00e9 F, Turchinovich A, Sinn P, Sohn C, Junkermann H, Schneeweiss A, Burwinkel B. Plasma microRNA panel for minimally invasive detection of breast cancer. PLoS One. 2013;8(10):e76729.","journal-title":"PLoS One"},{"issue":"1","key":"1196_CR129","doi-asserted-by":"crossref","first-page":"e53141","DOI":"10.1371\/journal.pone.0053141","volume":"8","author":"EK Ng","year":"2013","unstructured":"Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A. Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One. 2013;8(1):e53141.","journal-title":"PLoS One"},{"issue":"2","key":"1196_CR130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/ddt426","volume":"23","author":"HW Chu","year":"2014","unstructured":"Chu HW, Cheng CW, Chou WC, Hu LY, Wang HW, Hsiung CN, Hsu HM, Wu PE, Hou MF, Shen CY, Yu JC. A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Hum Mol Genet. 2014;23(2):355\u201367.","journal-title":"Hum Mol Genet"},{"key":"1196_CR131","doi-asserted-by":"crossref","unstructured":"Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Gr\u00f8nb\u00e6k K, Federspiel B, Lund AH, Friis-Hansen L. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer. 2011;10.","DOI":"10.1186\/1476-4598-10-29"},{"issue":"17","key":"1196_CR132","doi-asserted-by":"crossref","first-page":"11807","DOI":"10.1074\/jbc.M112.430934","volume":"288","author":"N Fils-Aim\u00e9","year":"2013","unstructured":"Fils-Aim\u00e9 N, Dai M, Guo J, El-Mousawi M, Kahramangil B, Neel JC, Lebrun JJ. MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new Signalling route through which transforming growth factor-\u03b2 Mediates the migration and actin dynamics of breast cancer cells. J Biol Chem. 2013;288(17):11807\u201323.","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"1196_CR133","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/bj3140555","volume":"314","author":"LN Berti-Mattera","year":"1996","unstructured":"Berti-Mattera LN, Wilkins PL, Madhun Z, Suchovsky D. P2-purigenic receptors regulate phospholipase C and adenylate cyclase activities in immortalized Schwann cells. Biochem J. 1996;314(Pt 2):555\u201361.","journal-title":"Biochem J"},{"issue":"21","key":"1196_CR134","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1158\/0008-5472.CAN-12-1600","volume":"72","author":"F Virgilio Di","year":"2012","unstructured":"Di Virgilio F. Purines, purinergic receptors, and cancer. Cancer Res. 2012;72(21):5441\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"1196_CR135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1750-3639.2008.00184.x","volume":"19","author":"D Nass","year":"2009","unstructured":"Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwick Yanai G, Elyakim E, Cholakh H, Gibori H, Spector Y, Bentwich Z, Barshack I, Rosenfeld N. MiR-92b and miR-9\/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009;19(3):375\u201383.","journal-title":"Brain Pathol"},{"issue":"9","key":"1196_CR136","first-page":"639","volume":"91","author":"ZF Zheng","year":"2011","unstructured":"Zheng ZF, Su HF, Zou Y, Peng Z, Wu SX. Expression profiles of microRNAs in radioresistant esophageal cell line. Zhonghua Yi Xue Za Zhi. 2011;91(9):639\u201342.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"1196_CR137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/erm.10.97","volume":"11","author":"RA Mukhtar","year":"2011","unstructured":"Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ. Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn. 2011;11(1):91\u2013100.","journal-title":"Expert Rev Mol Diagn"},{"key":"1196_CR138","first-page":"948098","volume":"2012","author":"NB Hao","year":"2012","unstructured":"Hao NB, L\u00fc MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012;2012:948098.","journal-title":"Clin Dev Immunol."},{"issue":"2","key":"1196_CR139","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.celrep.2011.12.005","volume":"1","author":"ML Squadrito","year":"2012","unstructured":"Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, De Palma M. miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep. 2012;1(2):141\u201354. doi: 10.1016\/j.celrep.2011.12.005 .","journal-title":"Cell Rep"},{"issue":"6","key":"1196_CR140","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3109\/02770903.2014.988222","volume":"52","author":"D Karo-Atar","year":"2015","unstructured":"Karo-Atar D, Itan M, Pasmanik-Chor M, Munitz A. MicroRNA profiling reveals opposing expression patterns for miR-511 in alternatively and classically activated macrophages. J Asthma. 2015;52(6):545\u201353. doi: 10.3109\/02770903.2014.988222 .","journal-title":"J Asthma"},{"issue":"2","key":"1196_CR141","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2015.05.031","volume":"365","author":"YJ Chen","year":"2015","unstructured":"Chen YJ, Zhang X, Wu ZS, Wang JJ, Lau AY, Zhu T, Lobie PE. Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells. Cancer Lett. 2015;365(2):182\u20139.","journal-title":"Cancer Lett"},{"issue":"9","key":"1196_CR142","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1210\/me.2014-1183","volume":"28","author":"S Elzein","year":"2014","unstructured":"Elzein S, Goodyer CG. Regulation of human growth hormone receptor expression by microRNAs. Mol Endocrinol. 2014;28(9):1448\u201359.","journal-title":"Mol Endocrinol"},{"key":"1196_CR143","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/bcr2766","volume":"12","author":"C Roth","year":"2010","unstructured":"Roth C, Rack B, Muller V, et al. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010;12:R90.","journal-title":"Breast Cancer Res"},{"key":"1196_CR144","doi-asserted-by":"crossref","first-page":"e47003","DOI":"10.1371\/journal.pone.0047003","volume":"7","author":"Y Sun","year":"2012","unstructured":"Sun Y, Wang M, Lin G, et al. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One. 2012;7:e47003.","journal-title":"PLoS One"},{"issue":"10","key":"1196_CR145","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1349-7006.2001.tb01064.x","volume":"92","author":"J Kurebayashi","year":"2001","unstructured":"Kurebayashi J, Otsuki T, Moriya T, Sonoo H. Hypoxia reduces hormone responsiveness of human breast cancer cells. Jpn J Cancer Res. 2001;92(10):1093\u2013101.","journal-title":"Jpn J Cancer Res"},{"key":"1196_CR146","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1476-4598-11-80","volume":"11","author":"AL George","year":"2012","unstructured":"George AL, Rajoria S, Suriano R, Mittleman A, Tiwari RK. Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Mol Cancer. 2012;11:80.","journal-title":"Mol Cancer."},{"key":"1196_CR147","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13048-014-0084-4","volume":"7","author":"S Chen","year":"2014","unstructured":"Chen S, Chen X, Xiu YL, Sun KX, Zong ZH, Zhao Y. microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells. J Ovarian Res. 2014;7:84.","journal-title":"J Ovarian Res"},{"issue":"1","key":"1196_CR148","first-page":"45","volume":"17","author":"X Xu","year":"2014","unstructured":"Xu X, Wu X, Wu S, Jiang Q, Liu H, Chen R, Sun Y. Study on miR-490-5p and miR-363 as novel biomarkers for the diagnosis of colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2014;17(1):45\u201350.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"1196_CR149","first-page":"117","volume":"28","author":"HT Nguyen","year":"2012","unstructured":"Nguyen HT, Li C, Lin Z, et al. The microRNA expression associated with morphogenesis of breast cancer cells in three-dimensional organotypic culture. Oncol Rep. 2012;28:117\u201326.","journal-title":"Oncol Rep"},{"issue":"2","key":"1196_CR150","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10549-013-2798-1","volume":"143","author":"E Tilch","year":"2014","unstructured":"Tilch E, Seidens T, Cocciardi S, Reid LE, Byrne D, Simpson PT, Vargas AC, Cummings MC, Fox SB, Lakhani SR, Chenevix TG. Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women. Breast Cancer Res Treat. 2014;143(2):385\u201392. doi: 10.1007\/s10549-013-2798-1 .","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1196_CR151","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.biopha.2014.07.014","volume":"68","author":"F Wang","year":"2014","unstructured":"Wang F, Yang Y, Fu Z, Xu N, Chen F, Yin H, Lu X, Shen R, Lu C. Differential DNA methylation status between breast carcinomatous and normal tissues. Biomed Pharmacother. 2014;68(6):699\u2013707. doi: 10.1016\/j.biopha.2014.07.014 .","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1196_CR152","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/cas.12813","volume":"106","author":"T Takeshita","year":"2015","unstructured":"Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Inao T, Sueta A, Fujiwara S, Omoto Y, Iwase H. Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer. Cancer Sci. 2015;106(11):1582\u20139. doi: 10.1111\/cas.12813 . Epub 2015 Oct 30.","journal-title":"Cancer Sci"},{"key":"1196_CR153","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13058-015-0575-2","volume":"17","author":"X Feng","year":"2015","unstructured":"Feng X, Li H, Dean M, Wilson HE, Kornaga E, Enwere EK, Tang P, Paterson A, Lees-Miller SP, Magliocco AM, Bebb G. Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer. Breast Cancer Res. 2015;17:65. doi: 10.1186\/s13058-015-0575-2 .","journal-title":"Breast Cancer Res."},{"key":"1196_CR154","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12885-015-1505-5","volume":"15","author":"G Cizeron-Clairac","year":"2015","unstructured":"Cizeron-Clairac G, Lallemand F, Vacher S, Lidereau R, Bieche I, Callens C. MiR-190b, the highest up-regulated miRNA in ER\u03b1-positive compared to ER\u03b1-negative breast tumors, a new biomarker in breast cancers? BMC Cancer. 2015;15:499. doi: 10.1186\/s12885-015-1505-5 .","journal-title":"BMC Cancer."},{"issue":"3","key":"1196_CR155","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/cas.12880","volume":"107","author":"A Shimomura","year":"2016","unstructured":"Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, Ono M, Takeshita F, Niida S, Shimizu C, Fujiwara Y, Kinoshita T, Tamura K, Ochiya T. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 2016;107(3):326\u201334. doi: 10.1111\/cas.12880 .","journal-title":"Cancer Sci"},{"key":"1196_CR156","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.1038\/srep09188","volume":"5","author":"M Hollm\u00e9n","year":"2015","unstructured":"Hollm\u00e9n M, Roudnicky F, Karaman S, Detmar M. Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer. Sci Rep. 2015;5:9188. doi: 10.1038\/srep09188 .","journal-title":"Sci Rep."},{"issue":"7","key":"1196_CR157","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1007\/s13277-014-1875-3","volume":"35","author":"D Tastekin","year":"2014","unstructured":"Tastekin D, Tas F, Karabulut S, Duranyildiz D, Serilmez M, Guveli M, Vatansever S. Clinical significance of serum tenascin-C levels in breast cancer. Tumour Biol. 2014;35(7):6619\u201325. doi: 10.1007\/s13277-014-1875-3 .","journal-title":"Tumour Biol"},{"issue":"10","key":"1196_CR158","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/carcin\/bgv102","volume":"36","author":"F Cordero","year":"2015","unstructured":"Cordero F, Ferrero G, Polidoro S, Fiorito G, Campanella G, Sacerdote C, Mattiello A, Masala G, Agnoli C, Frasca G, Panico S, Palli D, Krogh V, Tumino R, Vineis P, Naccarati A. Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort. Carcinogenesis. 2015;36(10):1144\u201353. doi: 10.1093\/carcin\/bgv102 .","journal-title":"Carcinogenesis"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T10:51:44Z","timestamp":1568544704000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-016-1196-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":158,"journal-issue":{"issue":"S12","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1186\/s12859-016-1196-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]},"article-number":"348"}}